Deterioration of Health-Related Quality of Life After Withdrawal of Risankizumab Treatment in Patients with Moderate to Severe Plaque Psoriasis: A Machine Learning Predictive Model
mediaposted on 2021-05-18, 12:28 authored by Adis journals on behalf of:, Kim A. Papp, Ahmed M. Soliman, Nicolae Done, Christopher Carley, Esteban Lemus Wirtz, Luis Puig
Article full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.